English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluDespite challenging macroeconomic conditions, Neocis, a leader in dental robotics, announced a successful funding round of $20M in 2023. The financing was secured to accelerate growth and involved participation from Mirae Asset Financial Group and NVIDIA.
Neocis’ Cutting-Edge Robotic Surgical System
Headquartered in Miami, Neocis is renowned for manufacturing Yomi®, the first FDA-cleared robotic surgical system for dental implant surgery. The Yomi platform, with 16 FDA 510(k) clearances, aids clinicians in all stages of implant placement through digital planning and haptic guidance. To date, over 40,000 implants have been placed with robotic assistance, with a dental implant being placed with Yomi approximately every six minutes.
Alon Mozes, Neocis’ co-founder and CEO, expressed gratitude for the investment, stating, “This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry.”
Growth and Utilization of Funds
Neocis, recognized as one of South Florida’s fastest-growing companies, plans to utilize the funds for various initiatives, including product development, sales enablement, and clinical education. The company moved into a larger headquarters in Miami’s Wynwood neighborhood last summer, equipped with a state-of-the-art manufacturing facility.
Soojung Kim, Investment Manager at Mirae Asset Capital, highlighted their excitement in supporting Neocis’ innovative mission in dentistry. Mohamed “Sid” Siddeek, corporate vice president and head of NVentures, emphasized the transformative impact of Neocis in dental implant procedures through robotics and AI.
Revolutionizing Dental Implant Surgery
Yomi, a computerized robotic navigational system, aids in both the planning and intraoperative phases of dental implant surgery. It is designed for use in partially and fully edentulous adult patients qualifying for dental implants.
Neocis, backed by venture capital from NVentures, Mirae Asset Financial Group, and other leading investors, collaborates with clinicians to develop innovative technologies. The company aims to advance patient care and improve the quality of life through its transformative approach to dental surgery.
For more information about Neocis and the Yomi platform, visit neocis.com.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.